.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Chubb
Farmers Insurance
Cantor Fitzgerald
Novartis
Mallinckrodt
Teva
Baxter
Dow

Generated: December 12, 2017

DrugPatentWatch Database Preview

Auranofin - Generic Drug Details

« Back to Dashboard

What are the generic sources for auranofin and what is the scope of auranofin freedom to operate?

Auranofin
is the generic ingredient in one branded drug marketed by Sebela Ireland Ltd and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for auranofin. Two suppliers are listed for this compound.

Medical Subject Heading (MeSH) Categories for auranofin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Sebela Ireland LtdRIDAURAauranofinCAPSULE;ORAL018689-001May 24, 1985RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: auranofin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sebela Ireland LtdRIDAURAauranofinCAPSULE;ORAL018689-001May 24, 1985► Subscribe► Subscribe
Sebela Ireland LtdRIDAURAauranofinCAPSULE;ORAL018689-001May 24, 1985► Subscribe► Subscribe
Sebela Ireland LtdRIDAURAauranofinCAPSULE;ORAL018689-001May 24, 1985► Subscribe► Subscribe
Sebela Ireland LtdRIDAURAauranofinCAPSULE;ORAL018689-001May 24, 1985► Subscribe► Subscribe
Sebela Ireland LtdRIDAURAauranofinCAPSULE;ORAL018689-001May 24, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Covington
Baxter
Express Scripts
US Department of Justice
Teva
Deloitte
McKinsey
Queensland Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot